ETF Securities Portfolio Insights – The potential benefits of real assets in a portfolio
Highlights
Up 1.4% since the end of 2015, the surge in US inflation benefitted most to commodities, up 16.3% on average, followed by natural resources stocks with 6.2%.
Following its rally in 2017, the upside potential of equities is questioned for 2018. Our simulated real asset portfolio allows for higher diversification and lower downside risk.
Based on historic simulations, an allocation of 20% in the real asset portfolio from a portfolio of 60% equities and 40% bonds increased the Sharpe ratio to 0.58 from 0.54 for the 60/40 benchmark.
In November 2016, we published an article showing how a portfolio of real assets would benefit from a rising inflation environment and improve the Sharpe ratio of a traditional portfolio of equities and bonds. In this note, we are looking back at how the simulated portfolio has performed and provide an analysis of the inflation situation for the year ahead.
Inflation over the past two years
Headline inflations for the US, UK and EU jumped by 1.8% on average since the end of 2015, with the UK reaching the highest level at 3% in December 2017. Core inflations, on the other hand, were mixed. In the UK, core inflation rose 1.1% since December 2015 while EU core inflation was flat and US core inflation fell. This highlights the substantial contribution of the food and energy component in the headline inflationrally, up 1.7% for the UK and the US and 1.2% for the EU.
So far, out of the major central banks, only the US Federal Reserve (Fed) has started tightening its monetary policy and increase interest rates. The European Central Bank (ECB) and Bank of England (BOE) remain on a wait and see mode as both economies remain subject to substantial uncertainties amidst Brexit. While markets have priced in the Fed’s three rate hikes for 2018, we believe they are still underestimating the potential of a policy mistake in a situation where US inflation overshoots and the economy overheats. With inflation in the US, UK and EU highly correlated to each other, we believe headline inflation will likely stabilise around their current levels for 2018.
Interestingly, half of the top 20 performers since the end of 2015 are equity stocks while the other half, with the exception of one, belongs to commodities and more specifically metals for the most part. Mining stocks have seen the best performance, up 133% non-annualised, followed by palladium (90%) and the basket of industrial metals (56%). Miners saw their earnings rise again after mid-2016. Capex growth also turned positive, potentially signalling the beginning of a new business cycle that could last for the next two to three years.
However, data since 1991 show that…
Among the real assets that perform best when US, EU and UK inflation rises, commodities represent nearly 40%, while infrastructure and real estate represent 30% and 17% respectively. Natural resources stocks and inflation-linked bonds making up for the remaining 13%.
Interestingly, the same analysis with EU inflation shows that inflation benefits mostly to infrastructure and real estate assets while rising UK inflation would push inflation-linked bonds to the top five.
The simulated real asset portfolio
The real asset portfolio we created in November 2016 has 10 constituents weighted equally: 3 baskets of commodities (broad, energy and agriculture), gold, platinum, global REITs and global real estate stocks, US energy MLPs, global infrastructure stocks and cash.
Since November 2016, the simulated real assets portfolio continues to lead inflation as illustrated below. Recent trend of the portfolio returns suggests that the inflationrally is likely over, remaining around its current level in the near term.
Equity as an asset class had an strong year in 2017, supported by positive economic data across the world and there are several indicators that the market has confidence that it will continue. The MSCI World index, used as a proxy for equities, rose by 33% since the end of 2015 compared to 7.7% for the bond index (the Barclays Capital Global Bond) and 17% for the simulated real assets portfolio. We, however, observe that overall, the real assets portfolio is less volatile than the MSCI World index and therefore has a better risk-adjusted return of 0.34 versus 0.30 for the equity index.
Starting from January 2018, we are replacing the basket of agriculture with the basket of industrial metals in order to reflect our bullish view on the sector for 2018. We had our call right for 2017 and we believe that metals with industrial applications will continue to benefit from rising economic activities across the world and more specifically from emerging markets.
Real assets contribution to a simulated portfolio of equities and bonds
As a reminder, by adding 20% of a portfolio of 60% equities and 40% bonds in the simulated real assets portfolio, the resulting simulated portfolio with real assets has 50% in equities, 30% in bonds, 10% in commodities, 4% in real estate, 4% in infrastructure and 2% in cash. Both portfolios rebalance once a year in January.
Following the recent equity rally, the simulated portfolio with real assets is underperforming the 60/40 benchmark by 0.2% per year since 2006. It is, however, less volatile, provides better protection from the downside risk and recovers faster to its previous peak. As a result, the simulated portfolio with 20% in real assets is better diversified than the benchmark, improving the Sharpe ratio from 0.54 with the 60/40 benchmark to 0.58
Important Information
This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (“ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (the “FCA”).
Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel Nordnet, SAVR, DEGIRO och Avanza.
Amundi S&P Global Health Care ESG UCITSETF DR EUR (D) (WELG ETF) med ISIN IE000JKS50V3, strävar efter att spåra S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. Det S&P-utvecklade ex-Korea LargeMidCap Sustainability Enhanced Health Care-indexet spårar stora och medelstora företag från hälso- och sjukvårdssektorn. Aktierna som ingår filtreras enligt ESG-kriterier (miljö, social och bolagsstyrning).
Den börshandlade fondens TER (total cost ratio) uppgår till 0,18 % p.a. Amundi S&P Global Health Care ESG UCITSETF DR EUR (D) är den billigaste ETF som följer S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care-index. ETFen replikerar det underliggande indexets prestanda genom fullständig replikering (köper alla indexbeståndsdelar). Utdelningarna i ETFen delas ut till investerarna (Årligen).
Amundi S&P Global Health Care ESG UCITSETF DR EUR (D) är en mycket liten ETF med 17 miljoner euro förvaltade tillgångar. ETFen lanserades den 20 september 2022 och har sin hemvist i Irland.
Investeringsmål
AMUNDI S&P GLOBAL HEALTH CARE ESG UCITSETF DR – EUR (D) försöker replikera, så nära som möjligt, resultatet av S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care Index (Netto Total Return Index). Denna ETF har exponering mot stora och medelstora företag i utvecklade länder. Den innehåller uteslutningskriterier för tobak, kontroversiella vapen, civila och militära handeldvapen, termiskt kol, olja och gas (inkl. Arctic Oil & Gas), oljesand, skiffergas. Den är också utformad för att välja ut och omvikta företag för att tillsammans förbättra hållbarhet och ESG-profiler, uppfylla miljömål och minska koldioxidavtrycket.
Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel DEGIRO, Nordnet, Aktieinvest och Avanza.
Amundi Global Corporate Bond UCITSETF investerar globalt i företagsobligationer med fast ränta, denominerade i lokal valuta och har en investment grade-rating. De måste ha en återstående löptid på minst ett år.
Andelsklassen är valutasäkrad mot amerikanska dollar och delar ut avkastningen.
Produktutbudet inom Deutsche Börses ETF- och ETP-segment omfattar för närvarande totalt 2 405 ETFer, 198 ETCer och 256 ETNer. Med detta urval och en genomsnittlig månatlig handelsvolym på mer än 21 miljarder euro är Xetra den ledande handelsplatsen för ETFer och ETPer i Europa.